New Tools for the Diagnosis, Prognosis and Treatment Follow-up in Chagas Disease
Status:
Completed
Trial end date:
2016-06-01
Target enrollment:
Participant gender:
Summary
Chagas disease is endemic to Latin America, and is of emerging importance in non-endemic
countries because migration of people infected with T. cruzi. Current methods for diagnosis
of T. cruzi infection are not ideal. Existing drugs for treatment are very limited, produce
severe side-effects, and their effectiveness cannot be properly evaluated. Reliable
biomarkers for prognosis, early diagnosis and effectiveness of treatment will be
investigated.
Details
Lead Sponsor:
Barcelona Centre for International Health Research